Vanguard Group Inc Lannett CO Inc Transaction History

Vanguard Group Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$0.45 - $0.86 $425 - $812	945 Added 0.13%	741,820 $385,000
Q3 2022 Nov 14, 2022	BUY	$0.46 - $0.63 $16,877 - $23,114	36,690 Added 5.21%	740,875 $333,000
Q2 2022 Aug 12, 2022	BUY	$0.47 - $0.87 $23,291 - $43,113	49,556 Added 7.57%	704,185 $409,000
Q1 2022 May 13, 2022	SELL	$0.75 - $1.77 $602,526 - $1.42 Million	-803,368 Reduced 55.1%	654,629 $516,000
Q4 2021 Feb 14, 2022	SELL	$1.56 - $2.93 $12,646 - $23,753	-8,107 Reduced 0.55%	1,457,997 $2.36 Million
Q3 2021 Nov 12, 2021	SELL	$2.91 - $4.83 $235,276 - $390,510	-80,851 Reduced 5.23%	1,466,104 $4.4 Million
Q2 2021 Aug 13, 2021	BUY	$4.17 - $5.74 $6.45 Million - $8.88 Million	1,546,955 New	1,546,955 $7.22 Million

Ticker LCI
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,960,000
Market Cap $1.29M
Description
Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nas...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.